✦ LIBER ✦

AAML0523: A report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia

✍ Scribed by Cooper, Todd M.; Alonzo, Todd A.; Gerbing, Robert B.; Perentesis, John P.; Whitlock, James A.; Taub, Jeffrey W.; Horton, Terzah M.; Gamis, Alan S.; Meshinchi, Soheil; Loken, Michael R.; Razzouk, Bassem I.

Book ID: 127145923
Publisher: John Wiley and Sons
Year: 2014
Tongue: English
Weight: 149 KB
Volume: 120
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.28674

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II trial of clofarabine and cyta

Phase I/II trial of clofarabine and cytarabine in children with relapsed/refractory acute lymphoblastic leukemia (AAML0523): A report from the Children's Oncology Group

✍ Cooper, Todd M.; Razzouk, Bassem I.; Gerbing, Robert; Alonzo, Todd A.; Adlard, K 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

Superior outcome of pediatric acute myel

Superior outcome of pediatric acute myeloid leukemia patients with orbital and CNS myeloid sarcoma: A report from the Children's Oncology Group

✍ Donna L. Johnston; Todd A. Alonzo; Robert B. Gerbing; Beverly J. Lange; William 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB

A Phase 2 study of bortezomib combined w

A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: A report from the Children's Oncology Group

✍ Horton, Terzah M.; Perentesis, John P.; Gamis, Alan S.; Alonzo, Todd A.; Gerbing 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

Phase II trial to assess the safety and

Phase II trial to assess the safety and efficacy of clofarabine in combination with low-dose cytarabine in elderly patients with acute myeloid leukemia

✍ Martínez-Cuadrón, David; Montesinos, Pau; Oriol, Albert; Salamero, Olga; Vidrial 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 102 KB

AAML03P1, a pilot study of the safety of

AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia : A report from the Children's Oncology Group

✍ Todd M. Cooper; Janet Franklin; Robert B. Gerbing; Todd A. Alonzo; Craig Hurwitz 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 385 KB 👁 2 views

PTPN11 mutations in pediatric patients w

PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer Group

✍ Loh, M L; Reynolds, M G; Vattikuti, S; Gerbing, R B; Alonzo, T A; Carlson, E; Ch 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 92 KB